KURA ONCOLOGY, INC. Other Income and Expense
KURA ONCOLOGY, INC. (KURA) reported Other Income and Expense of $4.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-12
- KURA ONCOLOGY, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was $4.69M, a 28.36% decline year-over-year.
- KURA ONCOLOGY, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was $5.49M, a 26.77% decline year-over-year.
- KURA ONCOLOGY, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $5.34M, a 1.60% increase year-over-year.
- KURA ONCOLOGY, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was $5.88M, a 7.32% increase year-over-year.
- KURA ONCOLOGY, INC. nonoperating income (expense) for fiscal 2025 was $25.26M, a 18.99% increase from fiscal 2024.
- KURA ONCOLOGY, INC. nonoperating income (expense) for fiscal 2024 was $21.23M, a 61.16% increase from fiscal 2023.
- KURA ONCOLOGY, INC. nonoperating income (expense) for fiscal 2023 was $13.17M, a 227.28% increase from fiscal 2022.
- KURA ONCOLOGY, INC. nonoperating income (expense) for fiscal 2022 was $4.03M, a 408.21% increase from fiscal 2021.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 4 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.69M 10-Q · filed 2026-08-12 | $10.18M 10-Q · filed 2026-08-12 | $15.52M derived: sum of 3 quarters · filed 2026-08-12 | $21.40M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $5.49M 10-Q · filed 2026-05-12 | $10.83M derived: sum of 2 quarters · filed 2026-05-12 | $16.71M derived: sum of 3 quarters · filed 2026-05-12 | $23.25M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $11.22M derived: sum of 2 quarters · filed 2026-03-05 | $17.77M derived: sum of 3 quarters · filed 2026-08-12 | $25.26M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $5.88M 10-Q · filed 2025-11-04 | $12.43M derived: sum of 2 quarters · filed 2026-08-12 | $19.92M 10-Q · filed 2025-11-04 | $25.18M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $6.54M 10-Q · filed 2026-08-12 | $14.04M 10-Q · filed 2026-08-12 | $19.30M derived: sum of 3 quarters · filed 2026-08-12 | $24.78M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $7.50M 10-Q · filed 2026-05-12 | $12.75M derived: sum of 2 quarters · filed 2026-05-12 | $18.23M derived: sum of 3 quarters · filed 2026-05-12 | $23.80M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $10.74M derived: sum of 2 quarters · filed 2026-03-05 | $16.30M derived: sum of 3 quarters · filed 2026-03-05 | $21.23M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $5.48M 10-Q · filed 2025-11-04 | $11.05M derived: sum of 2 quarters · filed 2025-11-04 | $15.97M 10-Q · filed 2025-11-04 | $19.95M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-06-30 | $5.57M 10-Q · filed 2025-08-07 | $10.49M 10-Q · filed 2025-08-07 | $14.47M derived: sum of 3 quarters · filed 2026-03-05 | $18.34M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-03-31 | $4.93M 10-Q · filed 2025-05-01 | $8.90M derived: sum of 2 quarters · filed 2026-03-05 | $12.77M derived: sum of 3 quarters · filed 2026-03-05 | $15.60M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2023-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.85M derived: sum of 2 quarters · filed 2026-03-05 | $10.68M derived: sum of 3 quarters · filed 2026-03-05 | $13.17M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $3.87M 10-Q · filed 2024-11-07 | $6.70M derived: sum of 2 quarters · filed 2024-11-07 | $9.20M 10-Q · filed 2024-11-07 | $11.24M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $2.83M 10-Q · filed 2024-08-08 | $5.33M 10-Q · filed 2024-08-08 | $7.37M derived: sum of 3 quarters · filed 2025-02-28 | $8.46M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $2.50M 10-Q · filed 2024-05-02 | $4.54M derived: sum of 2 quarters · filed 2025-02-28 | $5.63M derived: sum of 3 quarters · filed 2025-02-28 | $6.19M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.13M derived: sum of 2 quarters · filed 2025-02-28 | $3.70M derived: sum of 3 quarters · filed 2025-02-28 | $4.03M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $1.09M 10-Q · filed 2023-11-02 | $1.65M derived: sum of 2 quarters · filed 2023-11-02 | $1.98M 10-Q · filed 2023-11-02 | $2.28M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $564.00K 10-Q · filed 2023-08-09 | $893.00K 10-Q · filed 2023-08-09 | $1.19M derived: sum of 3 quarters · filed 2024-02-27 | $1.50M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $329.00K 10-Q · filed 2023-05-10 | $624.00K derived: sum of 2 quarters · filed 2024-02-27 | $935.00K derived: sum of 3 quarters · filed 2024-02-27 | $919.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $606.00K derived: sum of 2 quarters · filed 2024-02-27 | $590.00K derived: sum of 3 quarters · filed 2024-02-27 | $792.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $311.00K 10-Q · filed 2022-11-03 | $295.00K derived: sum of 2 quarters · filed 2022-11-03 | $497.00K 10-Q · filed 2022-11-03 | $670.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | -$16.00K 10-Q · filed 2022-08-03 | $186.00K 10-Q · filed 2022-08-03 | $359.00K derived: sum of 3 quarters · filed 2023-02-23 | $784.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $202.00K 10-Q · filed 2022-05-04 | $375.00K derived: sum of 2 quarters · filed 2023-02-23 | $800.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.49M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $598.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.28M derived: sum of 3 quarters · filed 2023-02-23 | $2.27M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $425.00K 10-Q · filed 2021-11-04 | $1.11M derived: sum of 2 quarters · filed 2021-11-04 | $2.10M 10-Q · filed 2021-11-04 | $3.20M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $686.00K 10-Q · filed 2021-08-05 | $1.68M 10-Q · filed 2021-08-05 | $2.77M derived: sum of 3 quarters · filed 2022-02-24 | $4.06M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $990.00K 10-Q · filed 2021-05-06 | $2.09M derived: sum of 2 quarters · filed 2022-02-24 | $3.37M derived: sum of 3 quarters · filed 2022-02-24 | $4.32M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.38M derived: sum of 2 quarters · filed 2022-02-24 | $3.33M derived: sum of 3 quarters · filed 2022-02-24 | $4.34M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.28M 10-Q · filed 2020-11-05 | $2.23M derived: sum of 2 quarters · filed 2020-11-05 | $3.24M 10-Q · filed 2020-11-05 | $3.78M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $948.00K 10-Q · filed 2020-08-06 | $1.96M 10-Q · filed 2020-08-06 | $2.50M derived: sum of 3 quarters · filed 2021-02-24 | $3.47M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $1.01M 10-Q · filed 2020-05-04 | $1.55M derived: sum of 2 quarters · filed 2021-02-24 | $2.52M derived: sum of 3 quarters · filed 2021-02-24 | $3.06M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.51M derived: sum of 2 quarters · filed 2021-02-24 | $2.05M derived: sum of 3 quarters · filed 2021-02-24 | $2.44M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $975.00K 10-Q · filed 2019-11-05 | $1.51M derived: sum of 2 quarters · filed 2019-11-05 | $1.90M 10-Q · filed 2019-11-05 | $2.15M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $537.00K 10-Q · filed 2019-08-01 | $924.00K 10-Q · filed 2019-08-01 | $1.17M derived: sum of 3 quarters · filed 2020-02-25 | $1.34M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $387.00K 10-Q · filed 2019-05-07 | $634.00K derived: sum of 2 quarters · filed 2020-02-25 | $800.00K derived: sum of 3 quarters · filed 2020-02-25 | $910.00K derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $413.00K derived: sum of 2 quarters · filed 2020-02-25 | $523.00K derived: sum of 3 quarters · filed 2020-02-25 | $643.00K 10-K · filed 2020-02-25 | |
| 2017-09-30 | $166.00K 10-Q · filed 2018-11-05 | $276.00K derived: sum of 2 quarters · filed 2018-11-05 | $396.00K 10-Q · filed 2018-11-05 | $527.00K derived: sum of 4 quarters · filed 2018-11-05 | |
| 2017-06-30 | $110.00K 10-Q · filed 2018-08-06 | $230.00K 10-Q · filed 2018-08-06 | $361.00K derived: sum of 3 quarters · filed 2018-08-06 | $493.00K derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-03-31 | $120.00K 10-Q · filed 2018-05-08 | $251.00K derived: sum of 2 quarters · filed 2018-05-08 | $383.00K derived: sum of 3 quarters · filed 2018-05-08 | $513.00K derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $263.00K derived: sum of 2 quarters · filed 2018-03-12 | $393.00K derived: sum of 3 quarters · filed 2018-03-12 | $807.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $132.00K 10-Q · filed 2017-11-07 | $262.00K derived: sum of 2 quarters · filed 2017-11-07 | $676.00K 10-Q · filed 2017-11-07 | $1.04M derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | $130.00K 10-Q · filed 2017-08-07 | $544.00K 10-Q · filed 2017-08-07 | $912.00K derived: sum of 3 quarters · filed 2017-08-07 | $1.25M derived: sum of 4 quarters · filed 2017-08-07 | |
| 2016-03-31 | $414.00K 10-Q · filed 2017-05-15 | $782.00K derived: sum of 2 quarters · filed 2017-05-15 | $1.12M derived: sum of 3 quarters · filed 2017-05-15 | $1.44M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $706.00K derived: sum of 2 quarters · filed 2017-03-14 | $1.03M derived: sum of 3 quarters · filed 2017-03-14 | $1.24M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $338.00K 10-Q · filed 2016-11-07 | $660.00K derived: sum of 2 quarters · filed 2016-11-07 | $872.00K 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $322.00K 10-Q · filed 2016-08-10 | $534.00K 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | $212.00K 10-Q · filed 2016-05-11 | ||||
| 2014-12-31 | $263.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |